Section Arrow
INVA.NASDAQ
- Innoviva
(Financial Status)
Quotes are at least 15-min delayed:2024/06/01 01:46 EDT
Last
 15.79
+0.44 (+2.87%)
Day High 
15.83 
Prev. Close
15.35 
1-M High
16.52 
Volume 
494.57K 
Bid
15.51
Ask
16.08
Day Low
15.37 
Open
15.5 
1-M Low
15.01 
Market Cap 
958.53M 
Currency USD 
P/E 6.85 
%Yield 1.58 
10-SMA 15.81 
20-SMA 15.71 
50-SMA 15.23 
52-W High 16.795 
52-W Low 12.22 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.24/2.24
Enterprise Value
1.41B
Balance Sheet
Book Value Per Share
11.27
Cash Flow
Cash Flow Yield
0.12
Income Statement
Total Revenue
310.46M
Operating Revenue Per Share
4.65
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.5285-0.0308-5.51%-- 
SMMTSummit Therapeutics8.685-2.235-20.47%28.74PE
KTRAKintara Therapeutics0.3166-0.0004-0.13%-- 
SRPTSarepta Therapeutics129.86+5.41+4.35%289.42PE
NVAXNovavax15.03-0.22-1.44%-- 
Quotes are at least 15-min delayed:2024/06/01 01:46 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.